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Abstract
Congenital hydrocephalus (CH) is a life-threatening medical condition in which excessive accumulation of CSF leads to
ventricular expansion and increased intracranial pressure. Stenosis (blockage) of the Sylvian aqueduct (Aq; the narrow
passageway that connects the third and fourth ventricles) is a common form of CH in humans, although the genetic basis of
this condition is unknown. Mouse models of CH indicate that Aq stenosis is associated with abnormal development of the
subcommmissural organ (SCO) a small secretory organ located at the dorsal midline of the caudal diencephalon.
Glycoproteins secreted by the SCO generate Reissner’s fibre (RF), a thread-like structure that descends into the Aq and is
thought to maintain its patency. However, despite the importance of SCO function in CSF homeostasis, the genetic program
that controls SCO development is poorly understood. Here, we show that the X-linked transcription factor SOX3 is
expressed in the murine SCO throughout its development and in the mature organ. Importantly, overexpression of Sox3 in
the dorsal diencephalic midline of transgenic mice induces CH via a dose-dependent mechanism. Histological, gene
expression and cellular proliferation studies indicate that Sox3 overexpression disrupts the development of the SCO
primordium through inhibition of diencephalic roof plate identity without inducing programmed cell death. This study
provides further evidence that SCO function is essential for the prevention of hydrocephalus and indicates that
overexpression of Sox3 in the dorsal midline alters progenitor cell differentiation in a dose-dependent manner.
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Introduction
Congenital hydrocephalus (CH) is a severe medical disorder
which has an incidence of 0.1–0.3% of live births [1]. CH is
characterised by the abnormal accumulation of cerebrospinal fluid
(CSF) and can result in death if not surgically treated using shunt
therapy. CSF is produced by the four choroid plexuses (ChP)
located in each of the brain ventricles and its rostral to caudal flow
is regulated by the coordinated beating of cilia present on
ependymal cells that line the ventricular surface. Non-communi-
cating hydrocephalus results from impaired CSF flow within the
ventricular system, which in the majority of cases is due to stenosis
of the Sylvian aqueduct (Aq), the narrow passage that connects the
third and fourth ventricles. CH has a significant genetic
component that is estimated to account for up to 40% of cases
[2]. X-linked recessive CH associated with stenosis of the Aq
(which comprises 5–15% of genetic cases) is the best characterised
form of the disorder and is caused primarily by mutations in the
L1CAM gene [3]. Familial forms of CH with autosomal dominant
and recessive modes of inheritance have also been described,
indicating the existence of additional causative genes [2].
However, to date, these genes have not been identified.
Of the model systems that have been used to investigate the
aetiology of hydrocephalus and CSF homeostasis, the mouse has
proven to be particularly useful. Loss-of-function mutations in
several genes that are required for ciliary generation, structure or
function in ependymal cells have been shown to cause post-natal
hydrocephalus [4,5,6,7]. In addition, ChP defects including loss
of cell polarity, abnormal morphology and cytoplasmic expan-
sion have been associated with a number of CH mouse models
[8,9,10]. In recent years, the subcommissural organ (SCO) has
also emerged as a major site of CH pathology [11]. The SCO is
a small secretary organ derived from prosomere 1, and is located
in the dorsal midline of the third ventricle near the dorso-
anterior opening of the Aq. Abnormal SCO development in
mice with loss-of-function mutations or ectopic/overexpression
of transgenes is also frequently associated with CH [10,12,13,
14,15,16].
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SCO-spondin, which polymerises to form Reissner’s fibre (RF), a
long threadlike structure that extends caudally through the Aq into
the spinal cord. Immunological blockage of RF generation results
in stenosis of the Aq and subsequent hydrocephalus [17],
indicating that RF is critical for maintaining CSF flow through
the Aq. Together, these studies point to a model in which RF
generated by the SCO maintains patency of the Aq thereby
preventing hydrocephalus [10,12,13,14,15,16]. However, the
causal link between SCO dysfunction and CH has not been
adequately resolved as some genetic mouse models of CH with
SCO dysplasia also have ciliary and/or ChP pathology [8,10,12]
or a lack of overt Aq stenosis [8,16]. Additional CH mouse models
with restricted SCO pathology are therefore required to resolve
this controversy.
Sox3 is an X linked transcription factor gene belonging to the
Sry-like HMG box family that is expressed in most stem/
progenitor cells in the developing central nervous system (CNS)
of vertebrates [18]. Duplication and mutations of SOX3 in humans
are associated with X-linked Hypopituitarism, a male-specific
syndrome characterised by hypothalamic-pituitary axis dysfunc-
tion and variable intellectual disability [19,20,21]. Sox3 null mice
also exhibit pituitary hormone deficiencies as well as abnormalities
of the hippocampus, cortex and hypothalamus, indicating that
SOX3 function is evolutionarily conserved [22].
Several studies indicate that Sox3 acts as a context-dependent
regulator of differentiation. Ectopic expression of Sox3 in the
genital ridge of transgenic mice and rearrangements of the SOX3
locus in humans are associated with XX male sex reversal due to
activation of the testis differentiation pathway [23]. In zebrafish,
gain-of-function and loss-of-function experiments indicate that
Sox3 is necessary and sufficient for neural plate formation [24,25].
In addition, enforced expression of Sox3 in chick neural tube
progenitor cells inhibits their differentiation [26,27]. Together,
these studies indicate that SOX3 has an important role in
generation and maintenance of neural stem/progenitor cells in
vertebrate embryos. However, SOX3 function in the developing
mammalian brain remains poorly understood at the cellular level.
Here we show that Sox3 is expressed throughout SCO
development in the mouse and that its overexpression in the
dorsal midline of the diencephalon, including the SCO, induces
CH in a dose-dependent manner. In particular, Sox3 overexpres-
sion blocks the development of the SCO primordium, leading to a
failure of RF generation and inhibition of diencephalic roof plate
identity.
Results
Dose-dependent CH in Sox3 transgenic mice
To investigate the phenotypic consequences of Sox3 overex-
pression in vivo, we generated transgenic mice by pronuclear
injection of a murine Sox3 genomic fragment containing 34 kb of
flanking sequence (Fig. 1A). Two of five transgenic founders/lines
developed features of CH including a dome-shaped cranium and
enlargement of the lateral ventricles (Fig. 2A,B). To investigate the
developmental and molecular basis of this phenotype, additional
transgenic mice were generated using a modified transgene in
which an IRES-EGFP reporter cassette was inserted into the Sox3
39UTR as a means to detect transgene expression (Fig. 1A) [23].
Six of the twenty founders developed severe hydrocephalus with
marked dorsal extension of the cranium, which resulted in death at
6–8 weeks. Lines were only able to be established from two of the
twenty Sox3 transgenic founders. The Nr (non-sex reversing) line
contained one copy of the transgene and the Sr (sex reversing) [23]
line contained two copies (Fig. 1B). Quantitative Western blot
analysis of 10.5 days post coitum (dpc) embryos indicated that
SOX3 levels were ,2-fold and ,3 fold higher than wild type in
the Nr/+ and Sr/+ lines, respectively, consistent with their
transgene copy number (Fig. 1C). Neither founder exhibited overt
CH but this phenotype was present in 18.7% and 30.6% of Nr/+
and Sr/+ adult transgenic descendants, respectively, and in 98.4%
of adults that carried both transgenes (referred to hereafter as Sr/
+;Nr/+; Table 1). Overt CH individuals displayed a domed-shaped
cranium due to accumulation of excess CSF prior to fusion of the
cranial sutures (Fig. 2C,D). While ventricular expansion was
clearly evident in the lateral and third ventricles, the fourth
ventricle was not affected in Sr/+, Nr/+ or Sr/+;Nr/+ mice from 3–
5 weeks old, consistent with non-communicating CH (Fig. S1A,B
and data not shown). Expansion of the lateral ventricles was
observed in Sr/+;Nr/+ embryonic brains at 18.5 dpc (Fig. 2E,F),
confirming the embryonic origin of the phenotype. Together,
these data indicate that Sox3 overexpression during embryonic
CNS development causes CH with dose-dependent phenotypic
penetrance.
Increased dosage of Sox3 leads to SCO dysplasia
Phenotypic analyses of other CH mouse models have indicated
that the SCO has an important role in maintaining CSF flow
through the Aq and that abnormal development of this organ is
associated with CH [10,12,13,14,16]. We therefore investigated
whether the endogenous Sox3 gene and the Sox3 transgene were
expressed in the SCO during development and at postnatal stages
in the Nr/+ and Sr/+ lines using SOX3- and transgene-specific
(EGFP) antibodies. In wild type embryos, the SCO primordium is
first evident at ,11.5 dpc as a strip of columnar epithelial cells at
the dorsal midline of prosomere 1. Robust expression of SOX3
was detected throughout the SCO primordium at this stage (data
not shown) and was maintained in the incipient organ during
progenitor cell proliferation at 12.5 dpc (Fig. 3A). By 15.5 dpc, at
which time most cells in the SCO have assumed their
characteristic tall columnar differentiated morphology, SOX3
expression was detected in all cells (Fig. 3E). SOX3 continued to
be expressed in the mature SCO at 18.5 dpc (Fig. S1C) and this
expression persisted into adulthood (Fig. 3I). Notably, SOX3
expression was markedly lower in the SCO region compared with
the periluminal neural progenitor cells flanking the SCO at 12.5,
15.5 and 18.5 dpc (n=3 for each stage; Figs. 3M,O, S2A,B,E,F).
Analysis of EGFP expression in Nr/+ and Sr/+ embryos revealed
that the Sox3 transgene was also expressed in the dorsal midline
and periluminal neural progenitor cells flanking the SCO. In fact,
EGFP was readily detected in the Nr/+ SCO primordium at 11.5
(data not shown), 12.5 and 15.5 dpc and was maintained at 18.5
dpc and adult SCO (Fig. 3D,H,L). As a consequence, the level of
SOX3 expression at the SCO was elevated to a level that was
comparable to that of the periluminal neural progenitor cells
flanking the SCO (Figs. 3M,N, S2C).
Next, we investigated whether SCO development was compro-
mised in Sox3 transgenic mice. Histological analysis of hydroce-
phalic P42 Nr/+ mice revealed striking hypoplasia of the SCO
(n=3), which was reduced to a thin layer of poorly organised
flattened cells lining the dorsal limit of the third ventricle
subadjacent to the posterior commissure (PC; Fig. S1G–I). While
these data suggest that SCO development was impaired by
overexpression of SOX3, it is also possible that these defects could
be secondary to increased intracranial pressure associated with
CH. Consequently, we examined embryonic SCO development,
in particular from 12.5 to 15.5 dpc during which the SCO
undergoes rapid proliferation and differentiation [28]. This
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PLoS ONE | www.plosone.org 2 January 2012 | Volume 7 | Issue 1 | e29041Figure 1. Structure, copy number and expression of the Sox3 transgene. A: Schematic representation of the transgene showing the Sox3
coding sequence (which is contained in a single exon) and the IRES-EGFP reporter cassette and flanking genomic sequence (not to scale). IRES
indicates the internal ribosome entry site. B: qPCR analysis of transgene copy number in the Sr/+ and Nr/+ lines demonstrating that they contain 2
and 1 copy of the transgene, respectively. Sox3 null (KO) genomic DNA was used as a negative control [22]. Sox1 quantification was performed as an
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animals because of the near complete penetrance of CH (Table 1).
At 12.5 dpc, Sr/+;Nr/+ embryos had formed a thickened,
pseudostratified columnar epithelium at the dorsal midline which
closely resembled stage-matched wild type SCO primordium
(n=5; Fig. 4A–D). However, slight irregularity of the PC fibres
was evident in some Sr/+;Nr/+ embryos (data not shown). By 13.5
dpc, the SCO primordium of Sr/+;Nr/+ embryos was markedly
thinner with fewer elongated SCO cells compared with wild type
embryos (n=3). In addition, the pineal recess and pineal gland,
midline structures that form immediately anterior to the SCO,
were not present in Sr/+;Nr/+ embryos (n=3; Fig. 4E–H). At 14.5
dpc, the SCO was barely discernable by histological analysis and,
unlike wild type tissue, densely-stained tall columnar cells were
absent from most of the SCO region (n=2; Fig. S1J,K). At 15.5
dpc, tall columnar cells were only found at the very posterior limit
of the Sr/+;Nr/+ SCO region (n=3; Figs. 4I–N, S1L–O). The PC
was grossly disorganised and the pineal gland and pineal recess
were absent. At 18.5 dpc, the dorsal midline of Sr/+;Nr/+
transgenic embryos contained a small remnant of SCO-like tissue.
Although this structure contained cells with elongated morphol-
ogy, they were less densely compacted than in the wild type SCO
and their nuclei were not localised basally. Apart from this region,
the PC was also missing in 18.5 dpc Sr/+;Nr/+ embryos (n=3; Fig.
S1P,Q). In contrast to the dorsal midline, other diencephalic
structures ventral to the SCO that express the transgene (data not
shown), including the ventral thalamus, dorsal thalamus, epithal-
amus and pretectum, appeared to be morphologically normal
(data not shown).
To assess SCO function, we studied SCO secretory function
using an anti-RF antibody [8]. RF-positive cells were present in
the wild type SCO at 15.5 and 18.5 dpc but were not detected in
the dorsal midline of stage-matched Sr/+;Nr/+ embryos (n=3;
Fig. 4O,P and data not shown). Together, these data indicate that
the SCO primordium appears initially to form in Sr/+;Nr/+
embryos but subsequently fails to develop into a functional mature
organ.
To investigate the mechanism that leads to SCO dysplasia, we
compared apoptotic cell death in wild type and Sr/+;Nr/+ SCO
primordia. Intriguingly, despite the apparent atrophy of the
transgenic SCO, we were unable to detect any active caspase-3
positive SCO cells in 12.5–14.5 dpc Sr/+;Nr/+ and wild type
embryos (Fig. S2I–P, data not shown). In contrast, active caspase-3
positive cells were readily detected in the trigeminal ganglia (data
not shown), a tissue that has previously been shown to express this
apoptotic cell marker between 12.5 and 14.5 dpc [29].
Next, we measured the proliferative index of transgenic SCO
progenitor cells at 12.5 dpc by BrdU labelling. A previous study
has shown that at this stage most SCO progenitor cells have been
born but have not yet terminally differentiated [28]. Quantifica-
tion of BrdU-positive cells demonstrated that the proliferative
index of the Sr/+;Nr/+ SCO was significantly (1.5-fold) higher
than stage-matched wild type controls (n=4; Fig. 5A–C and Fig.
S2U–X). These data suggest that the failure of the SCO to mature
in Sox3 Sr/+;Nr/+ transgenic embryos is not due to apoptotic cell
death and that Sox3 overexpression may alter the fate of the cells in
the dorsal midline.
Previous analysis of Sox3 overexpression in the chick neural
tube indicated that SOX3 inhibits neural differentiation through
maintenance of a progenitor cell state [26,27]. We therefore
hypothesised that Sox3 overexpression inhibited the differentia-
tion of SCO progenitors, resulting in the persistence of an
immature SCO that lacks terminally differentiated elongated cells
expressing RF. To test this hypothesis, we required SCO-
progenitor specific markers, which, unfortunately, have not been
described. To address this, we interrogated the Allen Brain Atlas
for genes that are expressed in the incipient SCO prior to
differentiation and are downregulated in the mature organ [30].
Fibrinogen C domain containing protein 1 (Fibcd1), which encodes a
transmembrane protein that binds to acetylated-glucosamine
[31], met these criteria and this was confirmed by in situ
hybridisation analysis of Fibcd1 expression in wild type SCO.
Fibcd1 was robustly expressed across most of the SCO
primordium at 12.5 dpc (Fig. 5D). Expression was highly variable
across the SCO at 15.5 dpc (Fig. 5E) and by 18.5 dpc, Fibcd1
expression could not be detected in the SCO but was evident in
endogenous autosomal control. C: Quantitative fluorescence Western blot analysis showing a 2–3-fold increase in SOX3 protein levels in 10.5 dpc Sr/
+ and Nr/+ embryos.
doi:10.1371/journal.pone.0029041.g001
Figure 2. Sox3 transgenic mice displayed CH. A,B: H&E stained
coronal section of adult Sox3 transgenic mouse brain without (A) and
with (B) overt hydrocephalus. Note the expanded lateral ventricles (LV),
thinning of cerebral cortex (double-headed arrow) and hippocampal
deformation (arrows) in the CH founder. C,D: Nr/+ adult mice showing
dome-shaped cranium (arrow) due to overt CH (D) and normal cranial
morphology (C). E,F: Nissl stained 18.5 dpc coronal brain sections of
wild type (E) and Sr/+;Nr/+ (F) 18.5 dpc embryonic brains. Note the
expansion of the lateral ventricles (LV) in the transgenic embryo (F).
Scale bar: 2 mm (A–B) and 1 mm (E–F).
doi:10.1371/journal.pone.0029041.g002
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SCO (Fig. 5F).
In 12.5 dpc Sr/+;Nr/+ SCO, which appears morphologically
normal, Fibcd1 expression was less robust than wild type SCO with
some cells displaying markedly reduced levels of expression
(Fig. 5G,H). qRT-PCR analysis of dissected SCO tissue confirmed
that expression of Fibcd1 in the 12.5 dpc Sr/+;Nr/+ SCO was
significantly reduced compared to wild type (Fig. 5K). At 14.5 dpc,
Fibcd1 expression in the Sr/+;Nr/+ SCO was markedly reduced
compared to wild type with only a subset of cells residing at the
posterior limit of the SCO expressing Fibcd1 (Fig. 5I,J). Together,
these data do not support the progenitor cell maintenance
hypothesis. Indeed, the premature downregulation of Fibcd1 in
some SCO cells as early as 12.5 dpc suggests that the transgenic
SCO is initially specified but rapidly loses its molecular identity
during early development.
Overexpression of Sox3 inhibits formation of the
diencephalic roof plate
Previous published data indicate that the establishment of dorsal
midline identity in prosomere 1 is critical for SCO development
and that Msx1 and Wnt1 (both of which are expressed the dorsal
midline/SCO primordium) are required for this process [14,16].
To investigate whether midline identity was perturbed by
increased expression of Sox3, we analysed Msx1 and Wnt1
expression at 12.5 dpc, the latest time-point at which in Sr/
+;Nr/+ embryos displayed a histologically normal SCO. In wild
type embryos, Msx1 and Wnt1 were expressed across the entire
diencephalic and rhombencephalic midline. In contrast, Msx1 and
Wnt1 expression in the dorsal midline of Sr/+;Nr/+ embryos was
largely restricted to the region posterior to the SCO (n=3;
Fig. 5L–O). qRT-PCR analysis of dissected SCO tissue confirmed
that Msx1 expression was significantly reduced in Sr/+;Nr/+
embryos compared to wild type (,2-fold; p=0.025, n=5; Fig. 5K)
and, although not statistically significant, Wnt1 expression was also
lower in 4 of the 5 samples analysed (data not shown). Expression
of Bmp6 in the dorsal midline/SCO region (which is dependent on
Msx1 activity in Prosomere 1) [14] was also significantly reduced in
Sr/+;Nr/+ embryos as shown by in situ hybridisation (n=3;
Fig. 5P,Q) and qRT-PCR (3-fold; p=0.027, n=3; Fig. 5K). These
data indicate that development of the dorsal midline is
compromised in Sox3 Sr/+;Nr/+ transgenic embryos.
To investigate whether the dorsal midline cells adopt an
alternative fate, we analysed the expression of Lhx5 and Sox14. At
12.5 dpc, these genes are expressed in dorso-lateral neuroepithelial
cells of the diencephalon and a thin band of cells spanning the
midline (Fig. 5R,T). Interestingly, analysis of Sr/+;Nr/+ embryos
revealed a marked expansion of the dorsal midline expression
domain (Fig. 5S,U; n=3 embryos). Given the loss of dorsal
midline marker expression Sr/+;Nr/+ embryos, these data suggest
that the diencephalic roof plate may adopt a lateral neuroepithelial
cell fate in response to high levels of Sox3 expression.
ChP development is not overtly affected in Sox3
transgenic embryos
CH is a heterogeneous disorder that can be caused by defects in
CNS regionsapart fromthe SCO,includingthe ChPs,which are the
maincentresforCSFproduction.TheChPsarelocatedinthelateral
ventricles and the midline of the third and fourth ventricles. Due to
the non-communicating nature of the hydrocephalus phenotype in
the Sox3 transgenicmodeland theretentionofCSF withintherostral
ventricles of the brain, it is unlikely that the ChP from the fourth
ventricle is contributing to the CH phenotype. In 12.5 dpc wild type
embryos, SOX3 is not expressed in the ChP epithelium of the third
ventricle and is expressed at a very low level in the ChP epithelia
within the lateral ventricles. Endogenous SOX3 was not detected in
any ChP at 15.5 dpc (data not shown). Weak transgene expression
was detected in the ChP primordia in the third and lateral ventricles
of Nr/+ embryos at 12.5 dpc but not at 15.5 dpc (data not shown).
However, histological analysis of the lateral and third ventricle ChP
at 15.5 dpc (n=2) did not reveal any abnormal features (Fig. S2 Q–
T),indicatingthatweaktransgeneexpression inthese regionsdid not
perturb development of the ChPs.
Discussion
CH is a severe medical disorder with a significant genetic
component. However, for most cases, the causative gene(s) is not
known. Here we show for the first time that overexpression of Sox3
in the dorsal midline of the murine diencephalon causes CH in a
dose-dependent manner. This phenotype is associated with a
critical failure in SCO development, in which progenitor cells
appear to be induced but fail to terminally differentiate into RF-
generating cells. These data strongly reinforce the causative link
between SCO dysfunction and CH, and indicate that Sox3
expression levels must be tightly regulated to ensure normal
development of the diencephalic roof plate.
It was first proposed by Overholser et al. in 1954 that RF is
generated by the SCO and that this fibre plays a role in preventing
closure of the Aq [32]. This hypothesis is supported by several loss-
of-function (Msx1, Rfx4 and Pax6) and gain-of-function (Adcyap1r1
and En1) mouse models of CH in which SCO development and/
or function is severely compromised [8,11,12,13,16,33]. However,
in most of these lines, additional pathologies in tissues that are
required for CSF production and flow (including the ChP and
ependymal cells) have prevented the establishment of a definitive
causative link between SCO dysfunction and CH. In contrast, our
data indicate that the CH phenotype in Sox3 transgenic mice is
caused specifically by SCO dysfunction alone. In particular, we
observed CH in Sr/+;Nr/+ embryos at 18.5 dpc. This precludes
involvement of ependymal motile cilia, which only become
Table 1. Dose-dependent penetrance of overt CH in Sox3 transgenic mice.
Genotype n Expected Frequency (%) Frequency (%) Percentage with overt hydrocephalus
Sr/+ 963 50 44.8* 30.6
Nr/+ 900 50 47.6 18.7
Sr/+;Nr/+ 364 25 17.3‘ 98.4
N and ‘: Significantly fewer progeny were present at weaning (*p=0.030, ‘p=0.001; Chi Square test).
Table showing the penetrance of overt CH in Sr/, Nr/+ and Sr/+;Nr/+ pups at weaning (approximately 3 weeks).
doi:10.1371/journal.pone.0029041.t001
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histological defects in the ChPs in the lateral and third ventricles.
Instead, the CH-related pathology in our model is restricted to the
dorsal midline of prosomere 1 from which the SCO is derived.
The failure of the SCO to develop in Sr/+;Nr/+ embryos becomes
apparent at 14.5 dpc, just prior to overt hydrocephalus at 18.5
dpc, and therefore cannot be attributed to secondary defects
associated with increased intracranial pressure. Furthermore, the
fourth ventricle of hydrocephalic Sox3 transgenic mice is not
enlarged, consistent with blockage of the Aq. Together these data
strongly support a direct role for the SCO/RF complex in the
prevention of CH by maintaining the patency of the Sylvian
Aqueduct.
In wild type embryos, Sox3 is expressed in neural progenitor
cells along the entire neuraxis of vertebrate embryos [34] as well as
a small subset of terminally differentiated neurons and glia in the
postnatal mouse brain [22, P. Thomas, unpublished data]. Here
we show that Sox3 is also expressed throughout SCO ontogeny.
The SCO primordium is first apparent at 10.5–11.5 dpc as a thin
band of ependymal cells in the diencephalic roof plate,
immediately subjacent to the PC [28]. Sox3 expression at this
stage encompasses the entire diencephalic roof plate (including the
SCO) and is generally at a lower level in the midline compared
with the lateral neuroectoderm. Sox3 expression in the SCO is then
maintained after terminal differentiation and into adulthood
(unlike the vast majority of CNS cells). This may reflect a role
for SOX3 transcriptional target genes in SCO function and/or
maintenance. In keeping with endogenous Sox3 expression, the
36 kb Sox3 genomic fragment used as a transgene in this study was
expressed throughout SCO development. However, other embry-
onic CNS regions that express high levels of endogenous Sox3
including the telencephalon and mesencephalon were negative for
transgene expression (K. Lee and P. Thomas, unpublished data),
suggesting that regulatory elements for these locations lie outside
the 36 kb transgene, consistent with a recent analysis of conserved
sequences flanking the SOX3 locus [35].
An important property of the Sox3 transgenic model is that
overexpression of Sox3 in the dorsal diencephalic midline causes
SCO dysplasia and CH via a dosa-sensitive mechanism. Single
(Nr/+) and dual (Sr/+) copy embryos develop CH in only 18% and
30% of cases, respectively, and in general have normal SCO
morphology. In contrast, compound hemizygous embryos with 3
copies of the transgene develop overt CH with extremely high
penetrance (over 98%) and invariably exhibit abnormal SCO
development. These data suggest that Sox3 expression levels in the
dorsal midline must exceed a critical threshold in order to exert an
effect on SCO development. The phenotypic consequences of Sox3
overexpression are first evident in the immature organ at 12.5–
13.5 dpc indicating that the Sox3 threshold effect occurs in SCO
progenitor cells and blocks their differentiation into terminally
differentiated RF-expressing cells. We tested three possible
mechanisms that could account for this defect. Firstly, gain-of-
Figure 3. Endogenous Sox3 and the Sox3 transgene are expressed in the developing and mature SCO. A–H: Sagittal sections of 12.5 dpc
(A–D) and 15.5 dpc (E–H) wild type (A,C,E,G) and Nr/+ (B,D,F,H) embryos immunostained for SOX3 (A,B,E,F) and EGFP (C,D,G,H). SOX3 is expressed in
all cells of the wild type and Nr/+ SCO. Note the presence of the EGFP signal and higher intensity of SOX3 signal in Nr/+ transgenic sections. I–L: Mid-
sagittal sections of adult wild type (I,K) and Nr/+ (J,L) brains showing expression of SOX3 and EGFP. M–P: Coronal sections of 12.5 dpc wild type (M,O)
and Sr/+;Nr/+ transgenic (N,P) SCO tissue. In wild type embryos, a lower level of endogenous SOX3 was detected in the SCO primordium in
comparison with periluminal cells flanking the SCO (asterisk in M). This difference in SOX3 signal intensity was not observed in Sr/+;Nr/+ embryos (N).
Arrows: PC (posterior commissure). Yellow arrowheads: points of invagination of the SCO primordium. White arrowhead: mesocoelic recess. In A–L,
anterior is to the left and dorsal to the top. Scale bar: 200 mm.
doi:10.1371/journal.pone.0029041.g003
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increased cell death in SCO progenitors. We found no evidence
of elevated apoptosis in the SCO region from 12.5 to 14.5 dpc
arguing against this possibility. Indeed, cell proliferation was
higher in the dorsal midline of Sr/+;Nr/+ embryos which was
more consistent with a change in cell fate. Secondly, overexpres-
sion of SOX3 could prevent differentiation of Fibcd1-expressing
SCO progenitors. This possibility is supported by a previous study
which showed that overexpression of SOX3 in chick neural tube
inhibits differentiation of neural progenitors [26,27]. Importantly,
we did not detect an overabundance of Fibcd1-expressing cells at
14.5 dpc in Sr/+;Nr/+ embryos suggesting that SCO progenitor
cells do not persist. A third possibility is that SCO progenitors are
induced but change their fate as a consequence of elevated Sox3
expression. Notably, Fibcd1is expressed at 12.5 dpc in Sr/+;Nr/+
embryos indicating that SCO progenitors are induced. However,
even at this early stage of SCO development, Fibcd1 expression
was weaker in Sr/+;Nr/+ embryos consistent with a change in fate.
Expression of Msx1 across the dorsal midline (which is required for
normal SCO development [14]) was also reduced. In addition,
dorsal midline expression of Wnt1 and Bmp6 was also downreg-
ulated in Sr/+;Nr/+ embryos. These genes have previously been
implicated in SCO development and are likely to provide
important patterning information for the dorsal diencephalon
Figure 4. Defective SCO development in Sr/+;Nr/+ embryos from 13.5 dpc. A–D: Nissl stained sagittal sections of 12.5 dpc wild type (A,C)
and Sr/+;Nr/+ (B,D) SCO primordia showing similar morphology and cell body density. C and D are boxed regions in A and B, respectively. E–H: Nissl-
stained sagittal sections of 13.5 dpc wild type (E,G) and Sr/+;Nr/+ (F,H) SCO region. Note the thinner SCO primordium and lack of pineal recess in the
Sr/+;Nr/+ embryo. I–N: Nissl-stained sagittal (I,J) and coronal (K–N) sections of 15.5 dpc wild type (I,K,M) and Sr/+;Nr/+ (J,L,N) SCO region. Note the
severely disrupted PC and absence of pseudostratified ependymal layer of the SCO in the Sr/+;Nr/+ embryo. M and N are boxed regions in K and L,
respectively. O–P: RF (red) and SOX3 (green) immunostaining of 15.5 dpc sagittal wild type (O) and Sr/+;Nr/+ (P) sections. Sr/+;Nr/+ transgenic
embryos maintain SOX3 expression in the dorsal midline but fail to generate RF. Arrows point to the SCO invagination in the roof plate and the
double-headed arrow to the mesocoelic recess. The hash sign indicates the SCO remnant. The asterisk indicates the approximate position where the
pineal gland should develop in Sr/+;Nr/+ embryos. The arrowhead indicates the pineal recess. EpTh: epithalamus. MHN: medial habenular nucleus. Pt:
pretectum. FR: fasciculus retroflexus. PC: posterior commissure. In A–H and K–P, anterior is to the left and dorsal to the top. Scale bars are 100 mm (C–
F, M,N), 200 mm (A,B,G,H,K,L) and 1 mm (I,J).
doi:10.1371/journal.pone.0029041.g004
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PLoS ONE | www.plosone.org 7 January 2012 | Volume 7 | Issue 1 | e29041Figure 5. Molecular and cellular defects in Sr/+;Nr/+ SCO development at 12.5 dpc and 14.5 dpc. A,B: Saggital section of 12.5 dpc wild
type (A) and Sr/+;Nr/+ (B) SCO region showing immuno-positive BrdU cells. C: Quantitation of BrdU showing a significant increase in proliferation in
the Sr/+;Nr/+ SCO. D–F: Section in situ hybridisation analysis of Fibcd1 expression in 12.5 dpc (D), 15.5 dpc (E) and 18.5 dpc (F) SCO. G,H: Sagittal
section in situ hybridisation analysis showing decreased Fibcd1 expression in the Sr/+;Nr/+ (H) SCO compared with wild type SCO (G) at 12.5 dpc. I,J:
In situ hybridisation analysis of wild type (I) and Sr/+;Nr/+ (J) 14.5 dpc sagittal sections showing robust Fibcd1 expression in the wild type SCO but not
in the dysplasic Sr/+;Nr/+ SCO region (hash). A small group of Fibcd1 positive cells were present at the posterior limit of the Sr/+;Nr/+ SCO region
(indicated by the plus sign). K: qRT-PCR analysis of SCO marker expression in 12.5 dpc wild type and Sr/+;Nr/+ SCO biopsies. L–O: Whole mount in
situ hybridisation showing Msx1 (L, N) and Wnt1 (M,O) expression at the dorsal midline of wild type (L,M) and Sr/+;Nr/+ (N,O) embryos at 12.5 dpc.
Wnt1 and Msx1 expression was lower in Sr/+;Nr/+ embryos rostral to the posterior limit of SCO (arrowhead). P, Q: In situ hybridisation analysis of
coronal sections from 12.5 dpc wild type (P) and Sr/+;Nr/+ (Q) embryos showing dramatic downregulation of Bmp6 expression in the transgenic SCO.
R–U: In situ hybridisation of coronal sections from 12.5 dpc wild type (R and T) and Sr/+;Nr/+ (S and U) demonstrating the dorsal domain of
dorsolateral neuroepithelial cells has expanded ventrally. MHN: medial habenular nucleus. PC: posterior commissure. Arrows point to the SCO
primordium invagination. Double-headed arrows indicate the mesocoelic recess. In A, B, D–J and L–O, anterior is to the left and dorsal to the top.
Scale bars are 100 mm (A–B, D–H), 200 mm (I–J, P–U) and 500 mm (L–O).
doi:10.1371/journal.pone.0029041.g005
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initially specified but are diverted from their normal developmen-
tal fate through overexpression of Sox3. It is also possible that Sox3
overexpression at the dorsal midline negatively impacts on the
induction of roof plate cells such that fewer Fibcd1-expressing cells
are generated at 12.5 dpc.
While the ultimate fate of Sox3 transgene-expressing cells in the
SCO region is not currently known, it is possible that they may
differentiate into cell type(s) that normally express relatively high
levels of SOX3. One such cell population is the lateral
neuroectodermal cells in the diencephalon. Indeed, the (elevated)
level of SOX3 expression in the SCO primordia of Sr/+;Nr/+
embryos is indistinguishable from that of periluminal neural stem/
progenitors located in adjacent dorso-lateral region. The higher
SOX3 dosage may thus divert the SCO progenitors from a dorsal
midline fate towards a neuroepithelial fate. This possibility is
supported by the expansion of Sox14 and Lhx5 expression domains
in the dorsal midline of Sr/+;Nr/+ embryos at 12.5 dpc. Further
gene expression studies are required to address this issue.
The molecular mechanism by which overexpression of Sox3
alters midline cell fate remains to be identified. However, given
that SOX3 can function as a transcriptional activator
[19,23,26,37], it seems likely that elevated expression of SOX3
target genes may directly influence differentiation. As SOX3
targets are not currently known, global gene expression and ChIP-
seq analysis will be required to explore this hypothesis further.
Alternatively, or in addition, higher expression of SOX3 in the
dorsal midline may reduce canonical Wnt signalling by direct
interaction with nuclear b-catenin [37,38], which may have a
significant impact on dorsal patterning of the diencephalon
[36,39,40,41]. Given that the Sox3 transgene is expressed across
the entire dorsal midline of the diencephalon, the impact of SOX3
overexpression may not be restricted to the SCO but could also
extend to other regions of the roof plate. This hypothesis is
supported by the abnormal morphology of the pineal gland in Sr/
+;Nr/+ embryos and further studies are underway to determine
the mechanism by which Sox3 overexpression affects roof plate
induction and differentiation across the entire Prosomere 1 region.
Finally, it is important to consider how SCO dysfunction in the
Sox3 transgenic mouse model relates to CH in humans. Although
the human SCO atrophies during early childhood [42,43], the
presence of SCO abnormalities in human fetuses with hydro-
cephalus suggest that SCO function may be required for CSF
homeostasis prior to birth [44]. We have shown previously that
duplication of SOX3 in 46 XY males is associated with CNS
defects and congenital hypopituitarism, [19,21,45]. However,
these patients (which are exceedingly rare) do not exhibit CH. This
is perhaps not surprising as SOX3 duplication in humans is
genetically most similar to the Nr/+ transgenic line which also
contains one additional copy of the Sox3 gene and has relatively
low penetrance of the CH phenotype. Further studies are therefore
required to determine the relationship between elevated SOX3
dosage and CH in humans. To this end, familial X-linked CH
cases in which L1CAM mutations have been excluded or
considered unlikely would appear to be a good starting point
[46,47].
Materials and Methods
Animal Ethics
Animal experiments were approved by the University of
Adelaide Animal Ethics Committee (S-074-2008). All studies were
conducted in accordance with the principles of animal replace-
ment and reduction and experimental refinement. Animals were
monitored daily for evidence of CH and, if distressed, were culled
immediately by cervical dislocation by an experienced investiga-
tor/animal technician.
Generation of mouse embryos and tissue collection
Generation of Sox3 transgenic mice by pronuclear injection was
described previously [23]. The Nr and Sr lines were maintained on
a C57BL/66CBA mixed genetic background. Sr/+;Nr/+ mice/
embryos were generated by either of the following crosses: Male
Sr/+;+/+6Female +/+;Nr/+ or Male +/+;Nr/+6Female Sr/+;+/
+. For BrdU analysis, pregnant mice were injected 2 h before
sacrifice intraperitoneally with 50 mg/kg BrdU (Sigma. cat.
No. 59-14-3) dissolved to 10 mg/ml in PBS (pH 7.4). Upon
collection, embryos were fixed in 4% paraformaldehyde in PBS,
washed 3610 min in PBS, cryoprotected in 30% sucrose in PBS,
embedded in OCT (Tissue Tek) and stored at 280uC. Tissue
sections (10–16 mm) were prepared using a Leica CM1900
cryostat.
Sr and Nr genotyping
The integration site of Sox3 transgene has been mapped in Sr
[23] and Nr lines. Primers were designed to amplify across the
integration site of Sr and Nr lines for PCR genotyping. Genomic
DNA was extracted from tail/embryo biopsies. The following
primers and cycle conditions were used. Sr transgenic primers: 59-
ACAGCCTTGTGAGTAGGTATGCTCTTG-39 and 59-TGG-
CTGTGGTAACCATTCATAAGGTAG-39; Gapdh primers: 59-
GGTCGGTGTGAACGGGTGAG-39 and 59-CCCTTTTGG-
CTCCACCCTTC-39. Sr cycle conditions: 95uC 2 min, 95uC
30 s, 60uC 30 s and 72uC 3 min (35 times), 72uC 7 min, 25uC
5 min. Nr transgenic/wild type primers: 59-CTGGGTTAGAG-
AGCAGCATCC-39 with either 59-GAGTGTTGGAGGGGG-
TTGAG-39 (transgenic) or 59-GTCCTACTCCCTCAACACC-
TGTC-39 (wild type); and Sry primers: 59-CACTGGCCTTT-
TCTCCTACC-39 and 59-CATGGCATGCTGTATTGACC-39.
Nr cycle conditions: 95uC3 0s ,9 5 uC3 0s ,6 0 uC 1 min and 72uC
40 s (35 times), 1 cycle of 72uC 5 min, 1 cycle of 22uC 10 min.
Quantitative Western blot analysis
10.5 dpc mouse embryos were lysed in 200 ml RIPA buffer
(150 mM NaCl, 1.0% Nonident P-40 (NP40), 0.5% deoxycholate,
0.1% SDS, 50 mM Tris-HCl, pH 7.4) supplemented with
protease and phosphatase inhibitors (10 mM b glycerol phosphate,
1 mM PMSF, 5 mM NaF, 10 mM sodium vanadate, 1 mg/ml
leupeptin and 0.005% v/v aprotinin). 40 mlo f5 6 SDS loading
buffer (312.5 mM Tris, 10% glycerol, 11.5% SDS, pH to 6.8,
0.1% Bromophenol blue, 10% b-mercaptoethanol) was added to
the samples. Samples were resolved by 12% SDS-PAGE and
subjected to immunoblot analysis using anti-hSox3 (R&D systems,
1:2500) and anti-b-tubulin (Cell Signalling Technologies, 1:1000)
antibodies. Signals were developed using ECL (West Pico, Pierce)
or ECF (Amersham Biosciences) substrates and quantified using
the Quantity One software (Bio-Rad). Three embryos for each
genotype were analysed.
qPCR quantitation of Sox3 transgene copy number
gDNA was isolated from tail tips using a High Pure PCR
Template Purification kit (Roche, cat. no.: 11796828001). qPCR
was performed on an ABI 7500 StepOne Plus platform using Fast
SYBR Green Master Mix (Applied Biosystems, cat. no. 4385610).
All qPCR runs consisted of 40 cycles of the following steps: 60uC
for 30 s, plate read, 95uC for 3 s. In a single qPCR run, one
sample of each genotype was assayed with primers against Sox1,
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subjected to qPCR analysis and results are presented as the
average of these 6 SD. Neurog3 was used as the reference gene and
the relative quantity of Sox1 for wild type XY was set as 1 and all
other genotypes were normalised to this. No genotypes deviated
significantly from wild type XY when compared pair-wise using a
Student’s t-test, illustrating that this assay is capable of accurately
measuring gene dosage. The relative quantity for Sox3 versus
Neurog3 was then normalised to a value of one for wild type XY
and the relative quantity of Sox3 for other genotypes was taken as a
measure of gene dosage. Estimation of gene dosage did not alter
when Sox1 was used as the reference gene instead of Neurog3.
Primers used were as follows: Sox3 (117 bp): 59- GAACGCAT-
CAGGTGAGAGAAG-39 and 59-GTCGGAGTGGTGCTCAG-
G-39; Sox1 (120 bp): 59- CCCCAGAGACACAACAACCT-39 and
59- AGTCACCCACTTCTGCTTCG-39, Neurog3 (171 bp): 59-
CCTCTCAGACGGTGGAGTTATATT-39 and 59-ATGTTG-
TACATAGCCTGCAAGTC-39.
Histology
For H&E staining, tissue sections were air-dried for 2 h at RT,
stained in 0.1% haematoxylin for 20 s, rinsed in water for 5 min,
immersed in 0.5% eosin for 15 s, rinsed in water for 5 s,
dehydrated in 50% EtOH followed by 70% EtOH for 10 s each,
equilibrated in 95% EtOH for 30 s, 100% EtOH for 1 min and
histolene for 15 s. Tissue sections were then mounted in xylene
based DePex mounting medium GurrH (Merck, cat. no.: 36125).
For Nissl staining, tissue sections were air-dried for 2 h at RT,
stained at 0.1% cresyl violet for 5 min and then washed in RO
water for 3 min. They were then dehydrated in 95% EtOH for
10 s, 100% for 10 s, equilibrated in histolene for 30 s and
mounted in xylene-based DePex mounting medium GurrH
(Merck, cat. no.: 36125).
Immunofluorescence
Immunofluorescence was performed on cryostat tissue sections as
described previously [23]. For BrdU staining, sections were air-dried
for2 hthenwashedwithPBS/0.1%Tritonfor10 min,denaturedin
2 N HCl at 37uC for 30 min, neutralised in 0.1 M borate buffer
(pH 8.5) at RT, washed 3 times in PBS for 10 min and then blocked
and immunostained as described previously [23]. Antibodies and
dilutions were: goat anti-SOX3 (R&D systems cat. no.: AF2569,
1:100), rabbit anti-EGFP (Abcam cat. no.: ab290, 1:1000), rabbit
anti-RF (kindly donated by A. Meiniel; 1:1000; [48]), sheep anti-
BrdU (Biodesign International cat. no.: M20107S, 1:1000), rabbit
anti-active Caspase-3 (BD pharmingen cat. no.: 559565, 1:1000),
donkey anti-goat IgG (Jackson ImmunoResearch Laboratories Inc.,
1:400), donkey anti-rabbit IgG Cy3 (Jackson ImmunoResearch
Laboratories Inc. cat. no.: 711-165-152, 1:400), donkey anti-sheep
IgG Cy3 (Jackson ImmunoResearch Laboratories Inc. cat. no.: 713-
165-147, 1:400), donkey anti-goat Cy5 (Jackson ImmunoResearch
Laboratories Inc. cat. no.: 705-175-147, 1:400).
Whole mount and section in situ hybridisation
Whole mount and section (10 mm) in situ hybridisation was
performed as described previously [23]. Probes were transcribed in
vitro from plasmid templates as follows: Wnt1 (HindIII, T7
polymerase; [49], kindly provided by M. Wassef); Msx1 (BamHI,
SP6 polymerase, a kind gift from Y. Lallemand & C. Ramos);
Fibcd1 (SpeI, T3 polymerase, IMAGE clone ID: 6848779); Bmp6
was amplified from cDNA using the following primers: 59-
GTTCTCCCCACATCAACGAC-39 and 59-CCAGCCAACCT-
TCTTCTGAG-39 and the product cloned into pGEMTH-T Easy
vector system I (Promega, Cat. no.: A1360) (SpeI, T7 polymerase).
Image analysis
Bright field images for whole mount tissue were captured using
a Olympus DP70 digital camera mounted on a Nikon SMZ1000
dissecting microscope with AnalySIS software. For tissue sections,
a Zeiss Axioplan 2 Imaging upright microscope with Axiovision
software was used to obtain immunofluorescence images, while
Zeiss Axiophot upright microscope with AnalySIS software was
used to obtain bright field images. All captured images were
processed by Adobe Photoshop CS. For quantitative BrdU
analysis, the following additional procedures were performed.
Prior to image capturing, BrdU-positive controls were used to
standardise the exposure time and the gain factor of the camera
using AxioVision Rel 4.7 software. The medial ganglionic
eminence does not have Sox3 transgene expression and was
expected to have similar level of cellular proliferation between wild
type and Sox3 transgenic individuals. Hence, the medial ganglionic
eminence served as a reference for BrdU labelling and detection
efficiency. For each image of the SCO, an image of the medial
ganglionic eminence from the same section was captured using
identical exposure time and gain factor. Subsequently, cell
counting was performed using ImageJ software [50] without
image manipulation and any knowledge of the genotype. For each
SCO, three sections separated at an interval of 20 mm were
counted. All counts were taken from an average of three repeated
counts. For each section, the quantity of BrdU positive SCO cells
was scored as the total number of BrdU-positive cells per total
number of SCO cells. Similarly, the number of BrdU-positive
medial ganglionic eminence cells was scored as the total number of
BrdU-positive cells per total number of cells from the selected
region of the medial ganglionic eminence. The final proliferative
index was obtained by normalising the number of BrdU-positive
SCO cells to that of the medial ganglionic eminence from the
same section. For data presentation, the proliferative indexes of
wild type embryos were set to 1, while those of the Sox3 transgenic
samples were calculated accordingly. Two-tailed unpaired Stu-
dent’s t-test was performed for statistical analysis.
SCO microdissection and RNA extraction
SCO microdissection was performed on stage-matched (53–55
somite) embryos. Embryos were placed on their side and an
incision horizontal to the anterior-posterior axis was made above
the optic placode. Excised tissue was placed ventral-side down and
a V-shaped cut was made to remove the telencephalon followed by
the removal of surface ectoderm. A ‘‘cup-like’’ tissue with intact
diencephalon and mesencephalon and most dorsal rhombenceph-
alon was left. Small incisions were made at the dorsal midline from
both the posterior and anterior end of the cup. This allowed the
cup to lay flat on the surface of the microscope stage like a ‘‘book’’.
The PC can be visualised as translucent tracts across the central
region of the tissue. The SCO was excised by cutting around the
anterior, posterior and lateral limits of the PC. Four SCO from
each genotype were pooled into one biological replicate. SCO
tissue was stored in RNAprotect Cell Reagent (Qiagen, no. #:
76526) until used. For RNA extraction, the tissue was homoge-
nised by brief sonication and QIAshredder (Qiagen, cat. no.:
79654) treatment. RNA was extracted using a RNeasy Plus Mini
Kit (Qiagen, cat. no.: 74134). RNA quality and concentration was
assayed using an Agilent 2100 Bioanalyser.
qRT-PCR analysis
cDNA was prepared using an Omniscript Reverse Transcrip-
tion kit (Qiagen, cat. no.: 205110) with 80 ng of RNA, 5.6 mM
oligo(dT)12–18 (Invitrogen, cat. no.: 18418-012), 1.25 mMd N 6
(Geneworks, cat. no.: RP-6), 10 U Proctector RNase inhibitor
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performed with Fast SYBR Green Master Mix (Applied Bio-
systems, cat. no.: 4385610) on ABI 7500 StepOne Plus platform.
All qPCR cycles consisted of 40 cycles of the following steps: 60uC
for 30 s, plate read, 95uC for 3 s. Primers used are as follows: Sox3
(117 bp): 59- GAACGCATCAGGTGAGAGAAG-39 and 59-GT-
CGGAGTGGTGCTCAGG-39; EGFP (95 bp): 59-ACGACGG-
CAACTACAAGACC-39 and 59- GTCCTCCTTGAAGTCGA-
TGC-39, Msx1 (109 bp): 59- GCCCCGAGAAACTAGATCG-39
and 59- TTGGTCTTGTGCTTGCGTAG-39, Wnt1 (103 bp): 59-
TACTGGCACTGACCGCTCT-39 and 59-GAATCCGTCAA-
CAGGTTCGT-39, Bmp6 (87 bp): 59-CAAGTCTTGCAGGAG-
CATCA-39 and 59-CCAGCCAACCTTCTTCTGAG39, Fibcd1
(101 bp): 59-CAGCTGGCTTCCAGGTCTAC-39 and 59-CCA-
ACCTCGGAAAAAGTTCA-39, Gapdh (143 bp): 59-ACCCAGA-
AGACTGTGGATGG-39 and 59-ATGCCAGTGAGCTTCCC-
GTTCAGC-39; Sdha (106 bp): 59-AACACTGGAGGAAGCA-
CACC-39 and 59-GCACAGTCAGCCTCATTCAA-39. Results
were normalised to Sdha. Controls for no reverse transcriptase and
no template controls were performed for product specificity. Melt
curve analysis was undertaken to ensure amplification efficiency.
Supporting Information
Figure S1 Characterisation of CH phenotype in Sox3 transgenic
mice. A,B: H&E stained sagittal sections of P26 brains showing
that the fourth ventricle was not expanded in Nr/+ CH mice (B) in
comparison to wild type (A). C–F: Immunohistochemical analysis
of SOX3 (red; C,E) and EGFP (green; D,F) expression in wild type
(C,D) and Nr/+ (E,F)18.5 dpc coronally sectioned embryos. Note
expression of the endogenous Sox3 gene and the Sox3 transgene in
the SCO and the slight dysmorphology of the SCO in the Nr/+
embryo. (D) and (F) are EGFP stains of (C) and (D), respectively.
G–I: H&E stained coronal sections of wild type (G), Nr/+ (H) and
Nr/++CH (I) adult brains. SCO hypoplasia was observed in Nr/+
mice. J,K: Nissl stained sagittal sections of wild type (J) and Sr/
+;Nr/+ (K) 14.5 dpc embryos. SCO dysplasia was evident in Sr/
+;Nr/+ embryos. A small remnant of SCO-like tissue was present
in the posterior region (indicated by #). L–Q: Nissl-stained sagittal
sections of wild type (L,N,P) and Sr/+;Nr/+ (M,O,Q) 15.5 dpc (L–
O) and 18.5 dpc (P,Q) embryos. (N) and (O) are boxed regions of
(L) and (M), respectively. The SCO remnant in Sr/+;Nr/+
embryos (#) has a similar appearance to wild type (M, O). Both
the SCO and pineal gland were missing in Sr/+;Nr/+ 18.5 dpc
embryos. Similar to 14.5 and 15.5 dpc embryos, elongated cells
resembling SCO ependymal cells were observed at the very
posterior limit of the SCO region of Sr/+;Nr/+ embryos (#). 4V:
fourth ventricle. Cer: cerebellum. EpTh: epithalamus. Asterisk:
region of missing pineal gland. Dorsal is towards the top and
anterior is towards the left (A,B,G–Q). Scale bars: 500 mm (A,B),
100 mm (C–I, N–O) and 400 mm (J–M, P–Q).
(TIF)
Figure S2 SOX3 expression, apoptosis analysis and ChP
morphology in wild type and Sox3 transgenic embryos. A–H:
SOX3 immunohistochemical analysis of wild type (A,B,E,F) and
Nr/+ (C,D,G,H) embryos. In wild type embryos, a lower level of
SOX3 was evident in the SCO at 15.5 dpc (A,B) and 18.5 dpc
(E,F) in comparison to flanking periluminal cells. This difference in
SOX3 expression was less obvious in single transgenic (Nr/+)
embryos (C,D,G,H). I–P: Sagittal sections showing the absence of
SCO cell apoptosis in wild type (I,J,M,N) and Sr/+;Nr/+ (K,L,O,P)
embryos at 12.5 dpc (I,K) and 13.5 dpc (M,O). Arrowheads
indicate non-specific staining. (J), (L), (N) and (P) are DAPI stains
of (I), (K), (M) and (O), respectively. Q–T: Nissl-stained sagittal
sections of wild type (Q,S) and Sr/+;Nr/+ (R,T) 15.5 dpc embryos
showing similar histology of ChP from the lateral and third
ventricles. U–X: Additional BrdU immunofluorescence (sagittal)
sections showing elevated cellular proliferation in the SCO region
of 12.5dpc Sr/+;Nr/+ embryos. 3V: third ventricle. LV: lateral
ventricle. Dorsal is towards the top and anterior is towards the left
(I–P and U–X). Scale bars: 100 mm (A–P and U–X), 25 mm (O–
T).
(TIF)
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